Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RITUXIMAB-PVVR for Microscopic polyangiitis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 174 adverse event reports in the FDA FAERS database where RITUXIMAB-PVVR was used for Microscopic polyangiitis.

Most Reported Side Effects for RITUXIMAB-PVVR

Side Effect Reports % Deaths Hosp.
Off label use 2,079 49.4% 209 502
Intentional product use issue 627 14.9% 56 146
Condition aggravated 514 12.2% 26 147
Death 338 8.0% 338 63
Covid-19 322 7.7% 39 135
Fatigue 318 7.6% 15 84
Dyspnoea 314 7.5% 27 104
Inappropriate schedule of product administration 311 7.4% 21 77
Headache 291 6.9% 8 77
Pruritus 288 6.8% 4 35
Nausea 286 6.8% 8 76
Malaise 275 6.5% 28 95
Pain 271 6.4% 13 79
Throat irritation 259 6.2% 1 30
Cough 249 5.9% 15 64

Other Indications for RITUXIMAB-PVVR

Rheumatoid arthritis (1,659) Granulomatosis with polyangiitis (745) Multiple sclerosis (106) Systemic lupus erythematosus (105) Interstitial lung disease (73) Glomerulonephritis membranous (65) Anti-neutrophil cytoplasmic antibody positive vasculitis (62) Sjogren's syndrome (54) Product used for unknown indication (52) Pemphigus (51)

Other Drugs Used for Microscopic polyangiitis

RITUXIMAB (714) AVACOPAN (667) PREDNISOLONE (150) CYCLOPHOSPHAMIDE (116) PREDNISONE (114) METHYLPREDNISOLONE (101) AZATHIOPRINE (90) MYCOPHENOLATE MOFETIL (57) MYCOPHENOLATE MOFETIL\MYCOPHENOLATE MOFETIL (41) METHOTREXATE (22)

Related Pages

RITUXIMAB-PVVR Full Profile All Microscopic polyangiitis Drugs RITUXIMAB-PVVR Demographics RITUXIMAB-PVVR Timeline